.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
US Department of Justice
Farmers Insurance
Merck
Fuji
QuintilesIMS
Argus Health
Mallinckrodt
Healthtrust

Generated: September 23, 2017

DrugPatentWatch Database Preview

TRI-LUMA Drug Profile

« Back to Dashboard

Which patents cover Tri-luma, and what generic Tri-luma alternatives are available?

Tri-luma is a drug marketed by Galderma Labs Lp and is included in one NDA. There are four patents protecting this drug.

This drug has twenty-six patent family members in eighteen countries.

The generic ingredient in TRI-LUMA is fluocinolone acetonide; hydroquinone; tretinoin. There are twelve drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the fluocinolone acetonide; hydroquinone; tretinoin profile page.

Summary for Tradename: TRI-LUMA

Patents:4
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list116
Clinical Trials: see list103
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TRI-LUMA at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Galderma Labs Lp
TRI-LUMA
fluocinolone acetonide; hydroquinone; tretinoin
CREAM;TOPICAL021112-001Jan 18, 2002RXYesYes► Subscribe► SubscribeY ► Subscribe
Galderma Labs Lp
TRI-LUMA
fluocinolone acetonide; hydroquinone; tretinoin
CREAM;TOPICAL021112-001Jan 18, 2002RXYesYes► Subscribe► SubscribeY ► Subscribe
Galderma Labs Lp
TRI-LUMA
fluocinolone acetonide; hydroquinone; tretinoin
CREAM;TOPICAL021112-001Jan 18, 2002RXYesYes► Subscribe► SubscribeY ► Subscribe
Galderma Labs Lp
TRI-LUMA
fluocinolone acetonide; hydroquinone; tretinoin
CREAM;TOPICAL021112-001Jan 18, 2002RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Tradename: TRI-LUMA

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,544,674Topical skin care composition► Subscribe
9,333,172Topical skin care composition► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: TRI-LUMA

Country Document Number Estimated Expiration
Japan4638234► Subscribe
Japan2010280738► Subscribe
Portugal1562531► Subscribe
South Korea20050083828► Subscribe
Hong Kong1223040► Subscribe
Brazil0314882► Subscribe
Canada2503539► Subscribe
European Patent Office3002004► Subscribe
MexicoPA05004404► Subscribe
Slovenia1562531► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Julphar
Fish and Richardson
Boehringer Ingelheim
Federal Trade Commission
Healthtrust
Merck
Deloitte
McKesson
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot